Počet záznamů: 1  

Renal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula

  1. 1.
    SYSNO ASEP0541694
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevRenal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula
    Tvůrce(i) Honetschlagerová, Z. (CZ)
    Gawrys, O. (CZ)
    Jíchová, Š. (CZ)
    Škaroupková, P. (CZ)
    Kikerlová, S. (CZ)
    Vaňourková, Z. (CZ)
    Husková, Z. (CZ)
    Melenovský, V. (CZ)
    Kompanowska - Jezierska, E. (PL)
    Sadowski, J. (PL)
    Kolář, František (FGU-C) RID, ORCID, SAI
    Novotný, J. (CZ)
    Hejnová, L. (CZ)
    Kujal, P. (CZ)
    Červenka, L. (CZ)
    Zdroj.dok.Kidney & Blood Pressure Research - ISSN 1420-4096
    Roč. 46, č. 1 (2021), s. 95-113
    Poč.str.19 s.
    Jazyk dok.eng - angličtina
    Země vyd.CH - Švýcarsko
    Klíč. slovacongestive heart failure ; hypertension ; aortocaval fistula ; renal blood flow ; renal vascular reactivity ; angiotensin II ; renal denervation
    Vědní obor RIVFA - Kardiovaskulární nemoci vč. kardiochirurgie
    Obor OECDCardiac and Cardiovascular systems
    CEPNV18-02-00053 GA MZd - Ministerstvo zdravotnictví
    Způsob publikováníOpen access
    Institucionální podporaFGU-C - RVO:67985823
    UT WOS000614589100001
    EID SCOPUS85100625214
    DOI10.1159/000513071
    AnotaceObjective: We examined if renal denervation (RDN) attenuates the progression of aortocaval fistula (ACF)-induced heart failure or improves renal hemodynamics in Ren-2 transgenic rats (TGR), a model of angiotensin II (ANG II)-dependent hypertension. Methods: Bilateral RDN was performed 1 week after creation of ACF. The animals studied were ACF TGR and sham-operated controls, and both groups were subjected to RDN or sham denervation. In separate groups, renal artery blood flow (RBF) responses were determined to intrarenal ANG II (2 and 8 ng), norepinephrine (NE) (20 and 40 ng) and acetylcholine (Ach) (10 and 40 ng) 3 weeks after ACF creation. Results: In nondenervated ACF TGR, the final survival rate was 10 versus 50% in RDN rats. RBF was significantly lower in ACF TGR than in sham-operated TGR (6.2 +/- 0.3 vs. 9.7 +/- 0.5 mL min(-1) g(-1), p < 0.05), the levels unaffected by RDN. Both doses of ANG II decreased RBF more in ACF TGR than in sham-operated TGR (-19 +/- 3 vs. -9 +/- 2% and -47 +/- 3 vs. -22 +/- 2%, p < 0.05 in both cases). RDN did not alter RBF responses to the lower dose, but increased it to the higher dose of ANG II in sham-operated as well as in ACF TGR. NE comparably decreased RBF in ACF TGR and sham-operated TGR, and RDN increased RBF responsiveness. Intrarenal Ach increased RBF significantly more in ACF TGR than in sham-operated TGR (29 +/- 3 vs. 17 +/- 3%, p < 0.05), the changes unaffected by RDN. ACF creation induced marked bilateral cardiac hypertrophy and lung congestion, both attenuated by RDN. In sham-operated but not in ACF TGR, RDN significantly decreased mean arterial pressure. Conclusion: The results show that RDN significantly improved survival rate in ACF TGR, however, this beneficial effect was not associated with improvement of reduced RBF or with attenuation of exaggerated renal vascular responsiveness to ANG II.
    PracovištěFyziologický ústav
    KontaktLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Rok sběru2022
    Elektronická adresahttps://doi.org/10.1159/000513071
Počet záznamů: 1